Greenrose Acquisition Corp.
GNRSW
Other OTC0.00
USD
+0.00
- -
CIK
0001790665
ISIN
US3953921117
CUSIP
395392111
Return %
Stock
S&P500
1Y
-100.00
26.84
3Y
-100.00
77.03
5Y
-100.00
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Nicole Conboy
- Full Time Employees
- 91
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- DE United States of America
- IPO Date
- May 11, 2020
- CIK
- 0001790665
- Similar Companies
- Business
- Greenrose Acquisition Corp. is a special purpose acquisition company (SPAC) that focuses on facilitating merger and acquisition transactions in various industries. Its primary business activity involves raising capital through initial public offerings (IPOs) and subsequently identifying and acquiring or merging with private companies to assist their transition to the public markets. The company operates primarily in the United States and targets sectors that present high growth potential. Greenrose Acquisition Corp. offers investors access to opportunities in emerging and established companies by providing capital and strategic guidance to target businesses. Its core services include sponsorship and management of IPOs, identification and evaluation of acquisition targets, structuring and facilitating business combinations, and investor relations management. Recently, Greenrose Acquisition Corp. has undertaken significant strategic moves, including forming new partnerships with financial and industry specialists to enhance its deal sourcing and execution capabilities. The company completed noteworthy funding rounds to boost its acquisition capital and has advanced discussions on several mergers and acquisitions within 2024 and early 2025. Greenrose has also expanded its operational focus to include technology and renewable energy sectors, aligning with current market trends. These changes reflect Greenrose Acquisition Corp.'s ongoing commitment to evolving as a dynamic player in the SPAC and corporate acquisition space. Founded in 2020, Greenrose Acquisition Corp. is headquartered in New York, New York, and is publicly traded under the ticker symbol GNRSW. The company serves institutional investors, private equity firms, and growth-oriented private companies seeking access to public capital markets. This description encapsulates Greenrose Acquisition Corp.'s core products and services and highlights its latest major corporate developments within the last two years, providing a comprehensive insight into its operational and strategic outlook.